Duration of nicotine replacement therapy use and smoking cessation: A population-based longitudinal study

American Journal of Epidemiology

Volumn 181, Issue 7, 2015, Pages 513-520

  Zhang, Bo ^a   Cohen, Joanna E ^a   Bondy, Susan J ^a   Selby, Peter ^a  

^a ONTARIO TOBACCO RESEARCH UNIT   (Canada)

Author keywords

logistic models; longitudinal studies; nicotine replacement therapy; smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; VARENICLINE;

ALKALOID; DISEASE TREATMENT; LONGITUDINAL GRADIENT; NUMERICAL MODEL; REGRESSION ANALYSIS; SMOKING;

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; POPULATION; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; EDUCATIONAL STATUS; MARRIAGE; ONTARIO; PROCEDURES; SEX RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UTILIZATION;

CANADA; ONTARIO [CANADA];

NICOTIANA TABACUM;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; EDUCATIONAL STATUS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MARITAL STATUS; ONTARIO; SEX DISTRIBUTION; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS;

EID: 84926674008     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu292     Document Type: Article

References (49)

1. Corelli RL, Hudmon KS. Medications for smoking cessation. West J Med. 2002;176(2):131-135.
2. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
3. Shiffman S, Gitchell J, Pinney JM, et al. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997;6(4): 306-310.
4. Balmford J, Borland R, Hammond D, et al. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011;13(2):94-102.
5. Paul CL, Walsh RA, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust N Z J Public Health. 2003;27(5):491-495.
6. Buck D, Morgan A. Smoking and quitting with the aid of nicotine replacement therapies in the English adult population. Results from the Health Education Monitoring Survey 1995. Eur J Public Health. 2001;11(2):211-217.
7. Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109(3):491-499.
8. Alberg AJ, Patnaik JL, May JW, et al. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis. 2005; 24(1):101-113.
9. Ferguson J, Bauld L, Chesterman J, et al. The English smoking treatment services: one-year outcomes. Addiction. 2005; 100(suppl 2):59-69.
10. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288(10):1260-1264.
11. Zhu S, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18(4):305-311.
12. Swartz SH, Cowan TM, Klayman JE, et al. Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med. 2005;29(4):288-294.
13. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005;365(9474):1849-1854.
14. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax. 2007;62(11): 998-1002.
15. Kasza KA, Hyland AJ, Borland R, et al. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013; 108(1):193-202.
16. Diemert LM, Bondy SJ, Victor JC, et al. Efficient screening of current smoking status in recruitment of smokers for populationbased research. Nicotine Tob Res. 2008;10(11):1663-1667.
17. Diemert L, Victor JC, Chaiton M, et al. Ontario Tobacco Survey Technical Report 1: Baseline Data. Toronto, ON, Canada: Ontario Tobacco Research Unit; 2010.
18. Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control. 2006;15(suppl 3):iii3-iii11.
19. Gilpin E, Pierce JP, Goodman J, et al. Reasons smokers give for stopping smoking: do they relate to success in stopping? Tob Control. 1992;1(4):256-263.
20. Centers for Disease Control (CDC). Smokers' beliefs about the health benefits of smoking cessation-20 U.S. communities, 1989. MMWR Morb Mortal Wkly Rep. 1990;39(38):653-656.
21. Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res. 2012;14(12):1483-1487.
22. Hyland A, Borland R, Li Q, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(suppl 3):iii83-iii94.
23. Fagerstrom K, Rutqvist LE, Hughes JR. Snus as a smoking cessation aid: a randomized placebo-controlled trial. Nicotine Tob Res. 2012;14(3):306-312.
24. Melikian AA, Hoffmann D. Smokeless tobacco: a gateway to smoking or a way away from smoking. Biomarkers. 2009; 14(suppl 1):85-89.
25. Hyland A, Li Q, Bauer JE, et al. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6(suppl 3):S363-S369.
26. Marques-Vidal P, Melich-Cerveira J, Paccaud F, et al. Prevalence and factors associated with difficulty and intention to quit smoking in Switzerland. BMC Public Health. 2011;11:227.
27. Siahpush M, Borland R, Scollo M. Factors associated with smoking cessation in a national sample of Australians. Nicotine Tob Res. 2003;5(4):597-602.
28. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007;97(8):1503-1509.
29. Lennox AS, Taylor RJ. Factors associated with outcome in unaided smoking cessation, and a comparison of those who have never tried to stop with those who have. Br J Gen Pract. 1994;44(383):245-250.
30. Prochazka AV, Caverly TJ. ACP Journal Club. Review: varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults. Ann Intern Med. 2012;157(6): JC3-JC7.
31. West R. Behavioural support programmes for smoking cessation: needs and opportunities. Eur J Public Health. 2000; 10(suppl 3):25-29.
32. Hanley JA, Negassa A, Edwardes MD, et al. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157(4):364-375.
33. Shiffman S, Brockwell SE, Pillitteri JL, et al. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102-111.
34. Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2013;22(1): 32-37.
35. Cokkinides VE, Ward E, Jemal A, et al. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119-122.
36. Burns EK, Levinson AH. Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prev Med. 2008;34(3):212-215.
37. Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res. 2004;6(suppl 3): S303-S310.
38. Shiffman S, Brockwell SE, Pillitteri JL, et al. Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. Drug Alcohol Depend. 2008;93(1-2):121-131.
39. Pasco JA, Williams LJ, Jacka FN, et al. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008;193(4):322-326.
40. Falk DE, Yi HY, Hiller-Sturmhöfel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health. 2006;29(3):162-171.
41. Fiore MC. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care. 2000;45(10):1196-1199.
42. Ghisletta P, Spini D. An introduction to generalized estimating equations and an application to assess selectivity effects in a longitudinal study on very old individuals. J Educ Behav Stat. 2004;29(4):421-437.
43. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159.
44. Velicer WF, Prochaska JO, Rossi JS, et al. Assessing outcome in smoking cessation studies. Psychol Bull. 1992;111(1):23-41.
45. GlasgowRE, Mullooly JP, Vogt TM, et al. Biochemical validation of smoking status: pros, cons, and data from four low-intensity intervention trials. Addict Behav. 1993;18(5):511-527.
46. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086-1093.
47. Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. Am J Public Health. 1995;85(2):183-192.
48. Wong SL, Shields M, Leatherdale S, et al. Assessment of validity of self-reported smoking status. Health Rep. 2012; 23(1):47-53.
49. Cummings KM, Hyland A. Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health. 2005; 26:583-599.